Skip to content

T. Rhee

2 papers in the library · 147 citations · publishing 2022-2023

Papers

Sort Most recent Most cited

Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression

Acta Psychiatrica Scandinavica September 8, 2023 Giacomo D’andrea, Mauro Pettorruso, T. Rhee et al. 8 citations

Depressive disorders represent a significant economic and health burden globally. This is particularly evident in treatment-resistant depression (TRD), commonly defined as the absence of a satisfactory response to at least two different antidepressant trials (as defined by the U.S. Food and Drug Administration/FDA and European Medicine Agencies/EMA). The foregoing TRD cases frequently manifest...

Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.

JAMA Psychiatry October 19, 2022 T. Rhee, S. Shim, B. Forester et al. 139 citations

Importance Whether ketamine is as effective as electroconvulsive therapy (ECT) among patients with major depressive episode remains unknown. Objective To systematically review and meta-analyze data about clinical efficacy and safety for ketamine and ECT in patients with major depressive episode. Data Sources PubMed, MEDLINE, Cochrane Library, and Embase were systematically searched using...